Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study (RESPECT)
A Randomized Controlled Trial Comparing Transoral Incisionless Fundoplication (TIF) Using EsophyX With Sham Procedure for the Treatment of PPI Dependent GERD Compared With Sham and Placebo Controls
Sponsor: EndoGastric Solutions
A NA clinical study on Gastroesophageal Reflux Disease and Hiatal Hernia, this trial is completed. The trial is conducted by EndoGastric Solutions and has accumulated 11 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2022 — Dec 2022 [monthly]
Completed NA
▶ Show 6 earlier versions
-
Jan 2021 — Jan 2022 [monthly]
Completed NA
-
Apr 2019 — Jan 2021 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Mar 2019 — Apr 2019 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Mar 2019 [monthly]
Active Not Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
Phase: PHASE3 → NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE3
First recorded
Apr 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- EndoGastric Solutions
For direct contact, visit the study record on ClinicalTrials.gov .